СОВРЕМЕНЫЕ ПРИНЦИПЫ КОМПЛЕКСНОГО ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ (ОБЗОР ЛИТЕРАТУРЫ И АНАЛИЗ СОБСТВЕНОГО МАТЕРИАЛА)
Аннотация
Обзор посвящен основным методам комплексного лечения генерализованного рака молочной железы. Проведен анализ международных исследований, целью которых явилась оценка эффективности хирургического лечения как этапа комплексного лечения больных раком молочной железы IV стадии. Рассмотрена роль современной лекарственной терапии как фактора, увеличивающего общую выживаемость
Об авторах
Д. Д. Пак
ФГБУ «Московский научно-исследовательский онкологический институт им. П.А. Герцена», г. Москва
Россия
Россия
Л. В. Болотина
ФГБУ «Московский научно-исследовательский онкологический институт им. П.А. Герцена», г. Москва
Россия
Россия
А. С. Сухотько
ФГБУ «Московский научно-исследовательский онкологический институт им. П.А. Герцена», г. Москва
Россия
Россия
Список литературы
1. Белохвостова А.С., Смирнова И.А., Енилеева А.А. Таргетная терапия в лечении HER2-позитивного рака молочной железы//Сибирский онкологический журнал. 2013. № 2 (56). С. 84-88
2. Чиссов В.И., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2010 году. М., 2012. 260 с
3. Adam R., Aloia T., Krissat J. et al. Is liver resection justified for patients with hepatic metastases from breast cancer?//Ann. Surg. 2006. Vol. 244 (6). P. 897-907
4. Andre F., Slimane K., Bachelot T. et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period//J. Clin. Oncol. 2004. Vol. 22 (16). P. 3302-3308
5. Bafford A.C., Burstein H.J., Barkley C.R. et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival//Breast Cancer Res. Treat. 2009. Vol. 115 (1). P. 7-12
6. Baum M., Demicheni R., Hrushesky W. et al. Does sugery unfavourably perturb the «natural history» of early breast cancer by accelerating the appearance of distant metastases?//Eur. J. Cancer. 2005. Vol. 41. P. 508-515
7. Bathe O.F., Kaklamanos I.G., Moffat F.L. et al. Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer//Surg. Oncol. 1999. Vol. 8 (1). P. 35-42
8. Blanchard D.K., Shetty P.B., Hilsenbeck S.G. et al. Association of surgery with improved survival in stage IV breast cancer patients//Ann. Surg. 2008. Vol. 247 (5). P. 732-738
9. Blazer D.G., Kishi Y., Maru D.M. et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases//J. Clin. Oncol. 2008. Vol. 26 (33). P. 5344-5351
10. Burzykowski T., Buyse M., Piccart-Gebhart M.J. et al. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer//J. Clin. Oncol. 2008. Vol. 26 (12). P. 1987-1992
11. Buzdar A.U., Blumenschein G.R., Smith T.L. et al. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED)//J. Surg. Oncol. 1979. Vol. 12 (1). P. 27-40
12. Buyse M., Piccart-Gebhart M.J., Burzykowski T. et al. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer//J. Clin. Oncol. 2008. Vol. 26 (12). P. 1980-1986
13. Coffey J.C., Wang J. H., Smith M.J. Excisional surgery for cancer cure. Therapy at a cost//Lancer Oncol. 2003. Vol. 4. P. 760-768
14. Fields R.C., Jeffe D.B., Trinkaus K. et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site metastasis//Ann. Surg. Oncol. 2007. Vol. 14 (12). P. 3345-3351
15. Friedel G., Pastorino U., Ginsberg R.J. et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases//Eur. J. Cardiothorac. Surg. 2002. Vol. 22 (3). P. 335-344
16. Gnerlich J., Jeffe D.B., Deshpande A.D. et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data//Ann. Surg. Oncol. 2007. Vol. 14 (8). P. 2187-2194
17. Greenberg P.A., Hortobagyi G.N., Smith T.L. et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer//J. Clin. Oncol. 1996. Vol. 14 (8). P. 2197-2205
18. Hackshaw A., Knight A., Barrett-Lee P. et al. Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer//Br. J. Cancer. 2005. Vol. 93 (11). P. 1215-1221
19. Hanrahan E.O., Broglio K.R., Buzdar A.U. et al. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors//Cancer. 2005. Vol. 104 (6). P. 1158-1171
20. Holmes F.A., Buzdar A.U., Kau S.W. et al. Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED): the M.D. Anderson experience//Breast Dis. 1994. Vol. 7. P. 7-20
21. Jackisch C. HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy//Oncologist. 2006. Vol. 11. Suppl. 1. P. 34-41
22. Jakobs T.F., Hoffmann R.T., Schrader A. et al. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer//Cardiovasc. Interven. Radiol. 2009. Vol. 32 (1). P. 38-46
23. Le Scodan R., Stevens D., Brian E. et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy//J. Clin. Oncol. 2009. Vol. 27 (9). P.137-138
24. Mahner S., Schirrmacher S., Brenner W. et al. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-Dglucose, conventional imaging and computed tomography for staging of breast cancer//Ann. Oncol. 2008. Vol. 19 (7). P.1249-1254
25. Miksad R.A., Zietemann V., Gothe R. et al. Progression-free survival as a surrogate endpoint in advanced breast cancer//Int. J. Technol. Assess. Health Care. 2008. Vol. 24 (4). P. 371-383
26. Olson J.A., Marcom P.K. Benefit or bias? The role of surgery to remove the primary tumor in patients with metastatic breast cancer//Ann. Surg. 2008. Vol. 247 (5) P. 739-740
27. O’Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer//Oncologist. 2005. Vol. 10 (3). P. 20-29
28. Rapiti E., Verkooijen H.M., Vlastos G. et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis//J. Clin. Oncol. 2006. Vol. 24 (18). P. 2743-2749
29. Rena O., Papalia E., Ruffini E. et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients//Eur. J. Surg. Oncol. 2007. Vol. 33 (5). P. 546-550
30. Retsky M., Bonadonna G., Demicheli R. Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients//Breast Cancer Res. 2004. Vol. 6 (4). P. 372-374
31. Rivera E., Holmes F.A., Buzdar A.U. et al. Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease//Breast J. 2002. Vol. 8 (1). P. 2-9
32. Ruiterkamp J., Ernst M.F., van de Poll-Franse L.V. et al. Surgical resection of the primary tumor is associated with improved survival in patients with distant metastatic breast cancer at diagnosis//Eur. J. Surg. Oncol. 2009. Vol. 35 (11). P. 1146-1151
33. Shien T., Kinoshita T., Shimizu C. et al. Primary tumor resection improves the survival of younger patients with metastatic breast cancer//Oncol. Rep. 2009. Vol. 21 (3). P. 827-832
34. Sinha P., Clements V.K., Miller S. et al. Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression//Cancer Immunol. Immunother. 2005. Vol. 54 (11). P. 1137-1142
35. Singletary S.E., Walsh G., Vauthey J.N. et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer//Oncologist. 2003. Vol. 8 (3). P. 241-251
36. Viadana E., Bross J., Pickren J. AmAutopsy Study of Some Routes of Dissemination of Cancer of the Breast//Br. J. Cancer. 1973. Vol. 27 (4). P. 336-340
Рецензия
Для цитирования:
Пак Д.Д., Болотина Л.В., Сухотько А.С. СОВРЕМЕНЫЕ ПРИНЦИПЫ КОМПЛЕКСНОГО ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ (ОБЗОР ЛИТЕРАТУРЫ И АНАЛИЗ СОБСТВЕНОГО МАТЕРИАЛА). Сибирский онкологический журнал. 2013;(5):54-58.
For citation:
Pak D.D., Bolotina L.V., Suhotko A.S. Current aspects of comprehensive treatmentfor advanced breast cancer (literature review and analysis of original material). Siberian journal of oncology. 2013;(5):54-58. (In Russ.)
Просмотров: 555
.png)
Послать статью по эл. почте 
